The World Health Organization (WHO) announced this Monday a new project to produce vaccines against avian flu with the help of messenger RNA (mRNA) technology; the same one used in the case of Covod-19.

Leading the project is the Argentine biopharmaceutical company Sinergium Biotech, with the support of the WHO and other organizations that take advantage of mRNA technology, as it allows for faster and more flexible production of vaccines.

With this new project, the WHO and others involved will seek to establish a global mRNA vaccine production network to respond more quickly and effectively to future pandemics, considering that avian flu could be a serious public health threat if it became a pandemic.

Thanks to this project, the capacity of low-income countries to develop and produce their own vaccines will be strengthened, reducing dependence on other countries and strengthening research and production areas in the pharmaceutical area.

M.Pino

Source: elespectador

(Reference image source: Unsplash+, in collaboration with Getty Images)

Visit our news channel on Google News and follow us to get accurate, interesting information and stay up to date with everything. You can also see our daily content on Twitter and Instagram

La entrada WHO works on mRNA vaccine project against bird flu apareció primero en Bitfinance.

The German biotechnology company Biontech plans to develop a messenger RNA vaccine against malaria in the coming years, the pharmaceutical company announced today.

The firm plans to start a clinical trial in late 2022. An mRNA vaccine (mRNA stands for messenger ribonucleic acid.) teaches the body’s cells to produce a protein or a portion of a protein that triggers an immune response against the pathogen without having to come into contact with it.

Biontech has announced its intention to develop a safe and highly effective mRNA vaccine that generates long-lasting immunity for the prevention of malaria. In addition, the company is exploring the possibility of creating production facilities in Africa that can manufacture mRNA-based vaccines.

Malaria is one of the most dangerous infectious diseases in the world. In 2019, the WHO recorded 229 million cases and more than 400,000 deaths, most of them in children under the age of five. For decades, researchers have looked for a reliable vaccine, but so far none have been approved.

Source: dpa

La entrada Biontech plans to develop a vaccine against malaria apareció primero en Bitfinance.